Reference Source

FITNESS FACTORY GROUP · 99-39 · UNITED KINGDOM

For FITNESS FACTORY GROUP, import alert is 99-39; country is UNITED KINGDOM; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; product is TESTAFLEX Hormone Augmentation | Clomadex | TESTAFLEX Hormone Augmentation | Clomadex; product code is 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C. | 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C; date published is 04/07/2017; address is Unit 108, Brunswick Business Park , Tower Street, , Liverpool, UNITED KINGDOM, verified against its source on 2026-09-30.

Firm
FITNESS FACTORY GROUP verified
Import alert
99-39
Import alert name
Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
Country
UNITED KINGDOM verified
Address
Unit 108, Brunswick Business Park , Tower Street, , Liverpool, UNITED KINGDOM verified
Date published
04/07/2017 verified
Product code
54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C. | 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C. each item verified
Product
TESTAFLEX Hormone Augmentation | Clomadex | TESTAFLEX Hormone Augmentation | Clomadex each item verified
FDA notes
The product appears to be misbranded within the meaning of; Section 403(e)(1) of the Act in that the product label fails to list the name and place of business of the manufacturer; packer; or distributor in accordance with 21 CFR 101.5. The product appears to be misbranded within the meaning of; Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of; Section 403(s)(2)(C) of the Act in that the product label fails to identify the part of the plant (e.g.; root; leaves) from which each botanical dietary ingredient in the product is derived; as required by 21 CFR 101.4(h)(1). The product appears to be misbranded within the meaning of; Section 403(q)(5)(F) of the Act in that the in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36. The product appears to be misbranded within the meaning of; Section 403(r)(6) of the Act in that the product label makes structure function claims but fail to bear the required dietary supplement disclaimer in accordance with 21 CFR 101.93(b). | The product appears to be misbranded within the meaning of; Section 403(e)(1) of the Act in that the product label fails to list the name and place of business of the manufacturer; packer; or distributor in accordance with 21 CFR 101.5. The product appears to be misbranded within the meaning of; Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of; Section 403(q)(5)(F) of the Act in that the in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36. The product appears to be misbranded within the meaning of; Section 403(r)(6) of the Act in that the product label makes structure function claims but fail to bear the required dietary supplement disclaimer in accordance with 21 CFR 101.93(b). | The product appears to be misbranded within the meaning of; Section 403(e)(1) of the Act in that the product label fails to list the name and place of business of the manufacturer; packer; or distributor in accordance with 21 CFR 101.5. The product appears to be misbranded within the meaning of; Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of; Section 403(s)(2)(C) of the Act in that the product label fails to identify the part of the plant (e.g.; root; leaves) from which each botanical dietary ingredient in the product is derived; as required by 21 CFR 101.4(h)(1). The product appears to be misbranded within the meaning of; Section 403(q)(5)(F) of the Act in that the in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36. The product appears to be misbranded within the meaning of; Section 403(r)(6) of the Act in that the product label makes structure function claims but fail to bear the required dietary supplement disclaimer in accordance with 21 CFR 101.93(b). | The product appears to be misbranded within the meaning of; Section 403(e)(1) of the Act in that the product label fails to list the name and place of business of the manufacturer; packer; or distributor in accordance with 21 CFR 101.5. The product appears to be misbranded within the meaning of; Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of; Section 403(q)(5)(F) of the Act in that the in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36. The product appears to be misbranded within the meaning of; Section 403(r)(6) of the Act in that the product label makes structure function claims but fail to bear the required dietary supplement disclaimer in accordance with 21 CFR 101.93(b). each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

FITNESS FACTORY GROUP Date Published : 04/07/2017 Unit 108, Brunswick Business Park , Tower Street, , Liverpool, UNITED KINGDOM

— accessdata.fda.gov, retrieved 2026-09-22

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Product code, Product and FDA notes

54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 04/07/2017 Desc: TESTAFLEX Hormone Augmentation Notes: The product appears to be misbranded within the meaning of; Section 403(e)(1) of the Act in that the product label fails to list the name and place of business of the manufacturer; packer; or distributor in accordance with 21 CFR 101.5. The product appears to be misbranded within the meaning of; Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of; Section 403(s)(2)(C) of the Act in that the product label fails to identify the part of the plant (e.g.; root; leaves) from which each botanical dietary ingredient in the product is derived; as required by 21 CFR 101.4(h)(1). The product appears to be misbranded within the meaning of; Section 403(q)(5)(F) of the Act in that the in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36. The product appears to be misbranded within the meaning of; Section 403(r)(6) of the Act in that the product label makes structure function claims but fail to bear the required dietary supplement disclaimer in accordance with 21 CFR 101.93(b). 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 04/07/2017 Desc: Clomadex Notes: The product appears to be misbranded within the meaning of; Section 403(e)(1) of the Act in that the product label fails to list the name and place of business of the manufacturer; packer; or distributor in accordance with 21 CFR 101.5. The product appears to be misbranded within the meaning of; Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of; Section 403(q)(5)(F) of the Act in that the in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36. The product appears to be misbranded within the meaning of; Section 403(r)(6) of the Act in that the product label makes structure function claims but fail to bear the required dietary supplement disclaimer in accordance with 21 CFR 101.93(b). 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C. Date Published: 04/07/2017 Desc: TESTAFLEX Hormone Augmentation Notes: The product appears to be misbranded within the meaning of; Section 403(e)(1) of the Act in that the product label fails to list the name and place of business of the manufacturer; packer; or distributor in accordance with 21 CFR 101.5. The product appears to be misbranded within the meaning of; Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of; Section 403(s)(2)(C) of the Act in that the product label fails to identify the part of the plant (e.g.; root; leaves) from which each botanical dietary ingredient in the product is derived; as required by 21 CFR 101.4(h)(1). The product appears to be misbranded within the meaning of; Section 403(q)(5)(F) of the Act in that the in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36. The product appears to be misbranded within the meaning of; Section 403(r)(6) of the Act in that the product label makes structure function claims but fail to bear the required dietary supplement disclaimer in accordance with 21 CFR 101.93(b). 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C. Date Published: 04/07/2017 Desc: Clomadex Notes: The product appears to be misbranded within the meaning of; Section 403(e)(1) of the Act in that the product label fails to list the name and place of business of the manufacturer; packer; or distributor in accordance with 21 CFR 101.5. The product appears to be misbranded within the meaning of; Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of; Section 403(q)(5)(F) of the Act in that the in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36. The product appears to be misbranded within the meaning of; Section 403(r)(6) of the Act in that the product label makes structure function claims but fail to bear the required dietary supplement disclaimer in accordance with 21 CFR 101.93(b).

— all from accessdata.fda.gov, retrieved 2026-09-22

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.